Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Manual on the Effective Investigation and Documentation of Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
A survival guide for clinicans.
3rd edition.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
A Handbook for country programmes
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
Key populations brief
Accessed 2017
Rapport sur les populations clès
Accessed November 2017
Informe sobre poblaciones clave